EUVIMEDEUVIMED entdecken
Metaanalyse

Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis

Jordi Remon, Guillermo Villacampa, Francesco Facchinetti, Massimo Di Maio, Florit Marcuse, Marcello Tiseo, Monique Hochstenbag, Lizza E L Hendriks, Benjamin Besse

European Journal of Cancer · 2023-02 · 180 · 117-124

DOI: 10.1016/j.ejca.2022.12.005 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Journal of Cancer, 2023-02. Verfasst von Jordi Remon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Medicine, Gustave Roussy, Villejuif, France. Electronic address: JORDI.REMON-MASIP@gustaveroussy.fr. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms, Glandular and Epithelial, Thymus Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsNeoplasms, Glandular and EpithelialThymus NeoplasmsHumansThymomaClinical Trials, Phase I as TopicClinical Trials, Phase II as TopicPlatinum

Stichwörter der Autor:innen

Advanced thymic epithelial tumoursAtezolizumabAvelumabImmune checkpoint blockersNivolumabPembrolizumab

Substanzen

Immune Checkpoint InhibitorsPlatinum

Autor:innen und Institutionen

  • Department of Cancer Medicine, Gustave Roussy, Villejuif, France. Electronic address: JORDI.REMON-MASIP@gustaveroussy.fr.
  • The Institute of Cancer Research, London, United Kingdom; Oncology Data Science, Vall D'Hebron Institute of Oncology (VHIO), Barcelona, Spain; SOLTI Breast Cancer Research Group, Barcelona, Spain.
  • Université Paris-Saclay, Institut Gustave Roussy, Inserm U981, Villejuif, France.
  • Department of Oncology, University of Turin, At Ordine Mauriziano Hospital, Turin, Italy.
  • Department of Respiratory Medicine, Maastricht University Medical Centre, GROW School for Oncology and Reproduction, Maastricht, the Netherlands.
  • Department of Medicine and Surgery, University of Parma, Parma, Italy; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

Zitieren

APA

Remon, J., Villacampa, G., Facchinetti, F., Di Maio, M., Marcuse, F., Tiseo, M., Hochstenbag, M., Hendriks, L. E. L., & Besse, B. (2023). Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis. European Journal of Cancer, 180, 117-124. https://doi.org/10.1016/j.ejca.2022.12.005

Vancouver

Remon J, Villacampa G, Facchinetti F, Di Maio M, Marcuse F, Tiseo M, et al. Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis. European Journal of Cancer. 2023;180:117-124. doi:10.1016/j.ejca.2022.12.005

BibTeX
@article{Remon2023,
  author = {Remon, Jordi and Villacampa, Guillermo and Facchinetti, Francesco and Di Maio, Massimo and Marcuse, Florit and Tiseo, Marcello and Hochstenbag, Monique and Hendriks, Lizza E L and Besse, Benjamin},
  title = {Immune checkpoint blockers in patients with unresectable or metastatic thymic epithelial tumours: A meta-analysis},
  journal = {European Journal of Cancer},
  year = {2023},
  volume = {180},
  pages = {117--124},
  doi = {10.1016/j.ejca.2022.12.005}
}
Kostenlos starten →